January 31, 2017
The Japan Atherosclerosis Society (JAS) announced an outline of its 2017 guidelines for the prevention of atherosclerotic cardiovascular diseases on January 29. The society points out that the safety of PCSK9 inhibitors in long-term administration has not been confirmed, but...read more